C.S. Group, a pioneering enterprise listed in the U.S. capital market that specializes in restoring the rare fungal species endemic to Taiwan—Taiwanofungus Camphoratus—through its proprietary innovation in cultivation technology, has recently achieved a successful uplisting to the OTCQB Venture Market. This milestone not only demonstrates the Group’s immense potential within the global biotechnology sector but also establishes a solid foundation for its future application to list on NASDAQ.
